Analyst Ratings for PRA Health Sciences Inc. (PRAH)Updated: 2017-07-26
An average rating of Buy has been given to PRA Health Sciences Inc. (NASDAQ:PRAH) by analysts covering the stock. Last month, PRAH received an average rating of Buy.
8 analysts declared PRAH a buy, 1 gave an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.
A number of analysts gave price targets for PRAH. The highest price target was 90, implying potential capital gains of 17.17 percent. The minimum price target given was 69, implying potential capital losses of -10.17 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.
Analysts have revised their earnings estimates upwards for this quarter, by about 0 percent on average, compared to last month. That number becomes -0.68 percent if we expand the time horizon to include the past 3 months instead of just one. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0.16 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of 0.32 percent in FY estimates.
Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. Also over the last month, 0 analysts increased their estimates for the FY earnings, while 0 analysts decreased their estimates.
Analysts estimate earnings of PRAH to grow at a rate of 79.29 percent. Another measure frequently examined by investors is the PEG ratio. A lower PEG ratio is favorable, because that is often interpreted as the company being fairly priced relative to its growth rate. People often look for the PEG ratio to be under 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. PRAH has a PEG ratio of 0.57.
In the last 52-weeks, PRAH has achieved a high of 79.98 and a low of 43.08. Today's price is 78.3 percent above the 52-week low, and below the high by 3.96 percent. PRAH has a price/earnings ratio of 45.18. Investors typically compare the P/E ratio to a company's peers in the industry. The PRAH value stock report compares PRAH to some of its peers using value stock charts. The stock has a market capitalization of $4.8 billion. PRAH is estimated to release their earnings results for the quarter on 0000-00-00, days from today.